Activities of Doru-Claudian FRUNZULICĂ related to 2018/0225(COD)
Shadow opinions (1)
OPINION on the proposal for a decision of the European Parliament and of the Council on establishing the specific programme implementing Horizon Europe – the Framework Programme for Research and Innovation
Amendments (6)
Amendment 92 #
Proposal for a decision
Annex I – paragraph 8
Annex I – paragraph 8
In the implementation of Horizon Europe, particular attention will be paid to ensuring a balanced and broad approach to research and innovation, which is not only limited to the development of new products processes and services on the basis of scientific and technological knowledge and breakthroughs, but also incorporates the use of existing technologies in novel applications and continuous improvement and non-technological and social innovation. A systemic, cross-disciplinary, cross-sectoral and cross-policy approach to research innovation will ensure that challenges can be tackled while also giving rise to new competitive businesses and industries, fostering competition, stimulating private investments and preserving the level playing field in the internal market. In line with Union commitments to the reduction and eradication of poverty, particular attention will be paid to innovation for the benefit of international development and humanitarian assistance.
Amendment 101 #
Proposal for a decision
Annex I – paragraph 18
Annex I – paragraph 18
The Commission will systematically identify and record the results of the research and innovation activities under the Programme and transfer or disseminate these results and knowledge produced in a non-discriminatory fashion to industry and enterprises of all sizes, public administrations, academia, civil society organisations and policy-makers within and outside the EU, in order to maximise the European added value of the Programme.
Amendment 105 #
Proposal for a decision
Annex I – paragraph 19
Annex I – paragraph 19
Greater impact will be obtained through aligning actions with other nations and regions of the world within an international cooperation effort of unprecedented scale. Based on mutual benefit, partners from across the world will be invited to join EU efforts as an integral part of initiatives in support of EU action for poverty- eradication, sustainability, reinforced research and innovation excellence, and competitiveness.
Amendment 109 #
Proposal for a decision
Annex I – paragraph 20
Annex I – paragraph 20
International joint action, particularly focused on addressing market failures, will ensure effective tackling of global societal challenges and neglected areas of research, achieving the Sustainable Development Goals, access to the world’s best talents, expertise and resources, and enhanced supply and demand of innovative solutions.
Amendment 119 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 3
Annex I – part II – point 1 – point 1.1 – paragraph 3
Health research and innovation research and innovation have played a significant part in this achievement but also in improving productivity and quality in the health and care industry. However, the EU continues to face novel, newly emerging or persisting challenges that are threatening its citizens and public health, the sustainability of its health care and social protection systems, as well as the competitiveness of its health and care industry. Major health challenges in the EU include: the lack of effective health promotion and disease prevention; the rise of non-communicable diseases; the spread of antimicrobial drug resistance and the emergence of infectious epidemics; increased environmental pollution; the persistence of health inequalities among and within countries affecting disproportionally people that are disadvantaged or in vulnerable stages of life; the detection, understanding, control, prevention and mitigation of health risks in a rapidly changing social, urban and natural environment; the increasing costs for European health care systems and the progressive introduction of personalised medicine approaches and digitalisation in health and care; and the increasing pressure on the European health and care industry to remain competitive in and by developing health innovation vis-a-vis new and emerging global players. Globally, deaths from preventable diseases remain unacceptably high, particularly for children. Access to essential medicines remains out of reach for many in the developing world, due to prohibitively high costs, or because insufficient investment has been made into tackling neglected diseases. Health research under Horizon Europe must be driven by the principles of the Doha Declaration on the TRIPS Agreement and Public Health to increase research into neglected diseases, ensure global access to essential medicines, recognise the right to healthcare as a human right, and stimulate new funding mechanisms to encourage greater collaborative efforts to tackle global health challenges in Europe and the developing world.
Amendment 146 #
Proposal for a decision
Annex I – part II – point 2 – point 2.2 – point 2.2.4 – paragraph 2 – indent 2
Annex I – part II – point 2 – point 2.2 – point 2.2.4 – paragraph 2 – indent 2
– The capacities of society to increase resilience and better manage and reduce disaster risk, including through nature-based solutions, by enhancing prevention, preparedness and response to existing and new risks